Merck (MRK) Q2 2025 Earnings Call Transcript

Powered byQuartr

Company Participants

  • Operator
  • Peter Dannenbaum - SVP - IR, Merck & Co
  • Robert Davis - Chairman & CEO, Merck & Co
  • Caroline Litchfield - EVP & CFO, Merck & Co
  • Dean Li - EVP & President - Merck Research Laboratories, Merck & Co
  • Daina Graybosch - Senior MD - Immuno-Oncology, Leerink Partners
  • Vamil Divan - MD & Senior Research Analyst, Guggenheim Securities, LLC
  • Chris Schott - Managing Director, JP Morgan
  • Asad Haider - Healthcare Analyst, Goldman Sachs
  • Evan Seigerman - MD & Senior Research Analyst, BMO Capital Markets
  • Umer Raffat - Senior Managing Director, Evercore ISI
  • Akash Tewari - Global Head - Biopharmaceutical Research, Jefferies
  • Terence Flynn - Equity Research Analyst, Morgan Stanley
  • Courtney Breen - Senior Research Analyst, Bernstein
  • Trung Huynh - Executive Director & Equity Research, UBS Group
  • Tim Anderson - Managing Director, Senior Equity Research Analyst, Bank of America
  • Alexandria Hammond - Director - Head of Therapeutics, Wolfe Research LLC
  • James Shin - Director - Biopharma Equity Research, Deutsche Bank
  • Mohit Bansal - Managing Director, Wells Fargo Securities